News

Diacetyl, or 2,3-butanedione, is a flavoring agent that becomes a toxic inhalant when aerosolized. It causes inflammation and ...
May 8, 2025 — A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve ...
The meta-analysis of 9 studies showed high sensitivity with slightly lower specificity with the less-invasive option for ...
A study led by the Barcelona Institute for Global Health (ISGlobal) in collaboration with the Clínic-IDIBAPS, has shown, for ...
The danger with lung cancer is that symptoms often don't appear until the harmful cells have spread throughout the body. However, there might be a few early signs of the disease that you could notice.
Scientists at the Barcelona Institute for Global Health (ISGlobal) led the study, published Thursday in The Lancet ...
Late-breaking findings on pulmonology, critical care, and sleep medicine will be presented at the American Thoracic Society ...
Officially known as bronchiolitis obliterans, popcorn lung is a rare but serious and irreversible disease that damages the tiny airways in the lungs, leading to persistent coughing, wheezing ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...
The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.